Drugs Made In America Acquisition (DMII) Liabilities and Shareholders Equity (2024 - 2025)
Drugs Made In America Acquisition (DMII) reported Liabilities and Shareholders Equity of $505.0 million for Q4 2025, up 365643.31% year-over-year from N/an in Q4 2024, and up 0.79% quarter-over-quarter from $501.0 million in Q3 2025.
Drugs Made In America Acquisition (DMII) Liabilities and Shareholders Equity (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMII) has 2 years of Liabilities and Shareholders Equity data on file, last reported at $505.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | 474.42 Mn |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | 309.37 Mn |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | 311.76 Mn |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | 310.55 Mn |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | 310.95 Mn |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | 308.50 Mn |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | 366.18 Mn |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | 272.82 Mn |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | 242.35 Mn |
| 10 | Drugs Made In America Acquisition | 129.34 Mn | 129.34 Mn | - | 504.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 504.96 Mn |
| Sep 30, 2025 | 501.01 Mn |
| Dec 31, 2024 | 138,064.00 |